Literature DB >> 19647407

Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: strain rate imaging in a model of hibernating myocardium.

Carsten Schneider1, Kai Jaquet, Stephan Geidel, Thomas Rau, Rainer Malisius, Sigrid Boczor, Tomacz Zienkiewicz, Karl-Heinz Kuck, Korff Krause.   

Abstract

BACKGROUND: The aim of this study was to evaluate the cardioprotective effects of bone marrow-derived stem cells on myocardial compliance in a chronic ischemia model regarding strain rate (SR) parameters during dobutamine stress echocardiography (DSE).
METHODS: Ameroid constrictors were placed around the circumflex arteries of 23 domestic pigs to induce chronic vessel occlusions. Fifteen pigs received transendocardially bone marrow derived stem cells, and 8 received placebo injections (a 0.9% solution of NaCl) into the ischemic region. At week 6, the animals were evaluated regarding myocardial fibrosis, neovascularization, apoptosis, and diastolic function during DSE.
RESULTS: Stem cell-injected hearts showed significantly less fibrosis, higher ejection fractions, significant neovascularization, and less ventricular dilatation than controls (P < .05). Strain rate imaging revealed improved diastolic function, with higher early diastolic SR values and lower E/Ea ratios compared with controls (P < .05). Early diastolic SR during DSE identifies viable myocardium (extent of fibrosis, r = 0.86, P = .0001).
CONCLUSION: The endocardial injection of stem cells improves diastolic function in chronic ischemic myocardium and helps attenuate postinfarction remodeling.

Entities:  

Mesh:

Year:  2009        PMID: 19647407     DOI: 10.1016/j.echo.2009.06.011

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  9 in total

Review 1.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

2.  A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart.

Authors:  Nicholas A Kouris; Jayne M Squirrell; Jangwook P Jung; Carolyn A Pehlke; Timothy Hacker; Kevin W Eliceiri; Brenda M Ogle
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

Review 3.  Myocardial ischemia in patients with diastolic dysfunction and heart failure.

Authors:  Thomas E Vanhecke; Robert Kim; Shaheena Z Raheem; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

Review 4.  Bone marrow cell injection for chronic myocardial ischemia: the past and the future.

Authors:  Jan van Ramshorst; Sander F Rodrigo; Martin J Schalij; Saskia L M A Beeres; Jeroen J Bax; Douwe E Atsma
Journal:  J Cardiovasc Transl Res       Date:  2011-01-07       Impact factor: 4.132

5.  Imaging Cell Therapy for Myocardial Regeneration.

Authors:  Hualei Zhang; Hui Qiao; Victor A Ferrari; Rong Zhou
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-11-25

6.  Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34⁺ cells in a rabbit model of myocardial infarction.

Authors:  Tong Li; Qunxing Ma; Meng Ning; Yue Zhao; Yuelong Hou
Journal:  Mol Cell Biochem       Date:  2013-10-29       Impact factor: 3.396

7.  A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction.

Authors:  Bojan Vrtovec; Sabina Frljak; Gregor Poglajen; Gregor Zemljic; Andraz Cerar; Matjaz Sever; Francois Haddad; Joseph C Wu
Journal:  Eur J Heart Fail       Date:  2022-07-20       Impact factor: 17.349

Review 8.  Potential and clinical utility of stem cells in cardiovascular disease.

Authors:  Korff Krause; Carsten Schneider; Kai Jaquet; Karl-Heinz Kuck
Journal:  Stem Cells Cloning       Date:  2010-03-26

Review 9.  Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells.

Authors:  Amitabh C Pandey; Jordan J Lancaster; David T Harris; Steven Goldman; Elizabeth Juneman
Journal:  Stem Cells Int       Date:  2017-12-17       Impact factor: 5.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.